Stocks and Investing Stocks and Investing
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017

Brian Abrahams Initiated (BIIB) at Hold and Held Target at $319 on, Sep 15th, 2017


Published on 2024-10-25 22:49:34 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $319 on, Sep 15th, 2017.

Brian has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeffrey Silber of "BMO Capital" Maintained at Hold with Increased Target to $377 on, Wednesday, September 13th, 2017
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $311 on, Wednesday, July 26th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


These are the ratings of the 2 analyists that currently disagree with Brian


  • Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017
  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017